Cannabis and Driving in Israel: The Law, the Tests and the Penalties (2026)

Israel had roughly 143,900 medical cannabis licence and prescription holders as of May 2026, an all-time high (how many medical cannabis patients are in Israel?), and possession of small amounts for personal use has been decriminalised since 2019. Neither of those facts changes what happens if you drive. Israeli traffic law treats cannabis in a driver's body as an offence in itself — not a question of whether you were actually impaired — and it does not carve out an exception for licensed patients. This is the single legal exposure that catches out Israeli patients and visiting drivers more often than any other, because it operates on a logic almost nobody expects.

This guide is general information, not legal or medical advice. Traffic-drug offences carry mandatory minimum penalties; consult an Israeli traffic lawyer about your own situation.

The offence: presence, not impairment

Driving under the influence sits in section 62(3) of the Traffic Ordinance, which makes it an offence to drive while intoxicated, carrying up to two years' imprisonment. Section 64B then defines who counts as intoxicated, and it is here that cannabis diverges sharply from alcohol.

Alcohol has a threshold: you are over it or you are not. Dangerous drugs have no threshold at all. Israeli law treats the presence of any quantity of a dangerous drug in a driver's body as sufficient, without the prosecution needing to prove actual intoxication at the wheel, and it does not distinguish between drug types or amounts (Israel Traffic Ordinance overview, Flasburg Law; Bochbot & Sales, traffic practice).

That gap matters enormously for cannabis specifically. THC metabolites persist in the body far longer than any plausible period of impairment — days in an occasional user, potentially weeks in a daily one. A patient who took an evening dose of oil and drives to work the following morning is, on the face of the statute, committing the offence, even though no one would call them impaired. The law was not designed around a population of 140,000-plus daily therapeutic users, and it has not been redesigned since that population appeared.

A medical licence is not a defence

This is the most consequential misunderstanding in the field. Holding a valid Israeli medical cannabis licence or prescription authorises you to possess and use cannabis. It does not authorise you to drive after using it, and Israeli law draws no distinction between a licensed patient and a recreational user once a driver tests positive.

The point is made from the other direction as well. The conditions attached to medical cannabis licences require patients not to drive or operate heavy machinery while under the influence of their medicine, alongside obligations not to share or sell it and to store it securely (Cannado, licence conditions; Leumit Health Services). Patients are told this at the point of licensing. It is nonetheless routinely treated as boilerplate rather than as the description of a criminal exposure that it is.

How police test

Israel's enforcement architecture was built out in stages. In December 2018 the Knesset passed provisions expanding police powers to test drivers for alcohol and drug levels (Library of Congress, Global Legal Monitor) — a change introduced alongside, and politically bound up with, the partial decriminalisation of personal cannabis use (Jerusalem Post).

In practice the process runs in two stages:

• Roadside saliva screening. Officers use a saliva device — Israeli forces have deployed both DrugWipe and Dräger units — which screens for cannabis, opiates, cocaine, amphetamines, benzodiazepines and other substances. This is a fast indication, not proof.
• Laboratory confirmation. A positive screen establishes grounds to require a blood or urine test, and it is that laboratory result that carries evidential weight. A driver cannot be convicted on a saliva result alone.

One procedural point is worth knowing: unlike alcohol testing, where an officer may demand a breath test from any driver without cause, a drug test requires reasonable suspicion. A positive saliva screen is itself one route to establishing that suspicion for the purposes of demanding a laboratory sample.

What a conviction costs

The penalties are severe and largely non-discretionary. A conviction under section 62(3) carries disqualification from holding a driving licence for not less than two years. If the driver was convicted of the same offence within the preceding year, the minimum rises to four years. Courts retain a narrow power to impose a shorter disqualification in special circumstances, but this is an exception, not the norm. Imprisonment of up to two years is available, and fines and suspended sentences are common in practice.

Cannabis-related driving exposure also interacts with the wider penalty structure discussed in our guide to cannabis possession penalties in Israel, where driving is treated as one of the situations that sits outside the simple administrative-fine ladder and can bring licence consequences of its own.

The unresolved policy gap

The most striking feature of the Israeli position is what is missing from it. There is no published clinical guidance from the Health Ministry or the road-safety authorities telling a licensed patient how long after a dose it is lawful, or safe, to drive — no stated interval, no formulation-specific advice, no distinction between an occasional 10:1 CBD oil user and someone inhaling high-THC flower several times a day. Patients are told not to drive "under the influence" and left to reconcile that with a statute that does not use the concept of influence at all. The gap between a prohibition defined by presence and an instruction phrased in terms of influence is where the real exposure sits, and it is the state, not the patient, that has left it open.

The subject resurfaced in the current reform debate. When a special Health Ministry committee published its recommendations on 3 May 2026, alongside the headline proposal to phase out smoked medical cannabis over three years, it also called for stricter reporting requirements around driving and firearms eligibility, mandatory training for prescribing clinicians and expanded clinical research (StratCann). Health Minister Haim Katz instructed the ministry's director to halt implementation work on those recommendations on 6 May 2026, citing potential harm to patients, so nothing has changed operationally. The direction of travel, however, points toward tighter reporting on patients who drive rather than toward a threshold-based defence. We track that reform in is Israel banning smoked medical cannabis?.

If you are a visitor renting a car

Tourists face the same rule with an added layer of risk. A foreign medical cannabis card gives you no standing in Israel at all — not for possession and certainly not at the wheel — and consumption that took place lawfully in another country before you flew is irrelevant to what a blood test finds here. A positive result on a rental-car stop means an Israeli criminal traffic proceeding, a disqualification that Israeli courts impose as a minimum, and potential immigration consequences that a resident would not face. The broader position for visitors is set out in can tourists use cannabis in Israel?.

Practical guidance for patients

There is no published Israeli safe-interval guidance, which means the burden of judgement sits with the patient and their prescriber. Realistically:

• Raise it explicitly with your prescribing physician and get their view recorded, particularly if driving is essential to your work.
• Treat the dosing schedule as a driving decision. Patients whose regimen allows evening-only dosing are in a materially different position from those dosing through the day.
• Do not rely on feeling unimpaired. The offence is defined by presence, so subjective sobriety is not a defence and will not survive a laboratory result.
• Understand that formulation does not change the law. Oils, inhalers and flower all deliver THC; the metered inhaler and oil formats give better dose control, not legal cover.
• CBD-only products below the 0.3% THC threshold sit outside the drug ordinance, but a full-spectrum product with measurable THC does not, and a mislabelled bottle offers no protection.

The bottom line

Israel prohibits driving with any detectable quantity of cannabis in the body, and a medical licence changes nothing about that. The minimum penalty on conviction is a two-year disqualification. Detection windows for THC extend well beyond the window of impairment, which means a compliant patient following their prescription can be committing an offence without being impaired — a gap no Israeli authority has yet closed with published clinical guidance.

Until Israel publishes clinical guidance or adopts an impairment-based standard, the only prudent position for a licensed patient is to treat cannabis use and driving as mutually exclusive. For how the rest of the legal framework fits together, see our Regulation hub, and for the patient side of the programme, our Patient Access hub.